A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer. (ARTSCANIII)
A Randomized Multicenter Phase III Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.
Sponsor: Lund University Hospital
Listed as NCT01969877, this PHASE3 trial focuses on Locally Advanced Head and Neck Cancer and remains completed. Sponsored by Lund University Hospital, it has been updated 11 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Oct 2020 — Jan 2021 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Sep 2019 — Oct 2020 [monthly]
Active Not Recruiting PHASE3
-
Jan 2019 — Sep 2019 [monthly]
Active Not Recruiting PHASE3
-
Oct 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE3
-
Mar 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Mar 2017 [monthly]
Recruiting PHASE3
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lund University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .